Exact Mass: 516.2876
Exact Mass Matches: 516.2876
Found 149 metabolites which its exact mass value is equals to given mass value 516.2876
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
L-Olivosyl-oleandolide
3-O-(alpha-L-olivosyl)oleandolide is a macrolide that is oleandolide having a 2,6-dideoxy-alpha-L-arabino-hexopyranosyl (alpha-L-olivosyl) residue attached at position 3. It has a role as a metabolite. It is a macrolide, a glycoside and a monosaccharide derivative. It is functionally related to an oleandolide. L-Olivosyl-oleandolide is a naturally occurring sesquiterpene lactone derivative that contains an olivosyl moiety, which is a specific type of ester derived from olivolic acid. The "L" in the name indicates that the olivosyl group is in the L-configuration, which refers to the spatial arrangement of atoms around the chiral center in the molecule. This compound is an example of a glycosylated sesquiterpene lactone, where the sesquiterpene lactone oleandolide is modified by the attachment of the olivosyl group. The presence of the olivosyl group can alter the biological properties of the parent compound, oleandolide, potentially affecting its pharmacological activities such as cytotoxicity, anti-inflammatory effects, and antimicrobial activity. L-Olivosyl-oleandolide can be found in certain plant species and may contribute to the plant's defense mechanisms against pathogens and herbivores. In its chemical structure, L-Olivosyl-oleandolide consists of a sesquiterpene lactone core with a lactone ring fused to a sesquiterpene framework, and it is appended with the L-olivosyl ester group, which adds complexity to its molecular structure and function. This compound is of interest in the fields of natural products chemistry and pharmacognosy for its potential therapeutic applications and as a subject of study for understanding the biosynthesis of such natural products.
6-O-Acetyl-2,3,4-tri-O-<(+)-3-methylvaleryl>-beta-D-glucose
(1beta,5beta,7alpha,8xi,9beta,10alpha,11alpha,14beta)-7,8,11,14-tetrahydroxypimar-15-en-1-yl beta-D-glucopyranoside|ent-isopimanervoside B
2,6-Diacetyl-3,4-diisobutyryl-1-O-octylglucopyranoside
2beta,15S,16,17,19-pentahydroxyisopimar-8(14)-ene 17-O-beta-D-glucopyranoside
Ile Gln Lys Glu
Lys Gln Ile Glu
Glu Ile Lys Gln
Glu Ile Gln Lys
Glu Lys Ile Gln
Glu Lys Leu Gln
Glu Lys Gln Ile
Glu Lys Gln Leu
Glu Leu Lys Gln
Glu Leu Gln Lys
Glu Gln Ile Lys
Glu Gln Lys Ile
Glu Gln Lys Leu
Glu Gln Leu Lys
Gly Arg Val Trp
Gly Arg Trp Val
Gly Val Arg Trp
Gly Val Trp Arg
Gly Trp Arg Val
Gly Trp Val Arg
Ile Glu Lys Gln
Ile Glu Gln Lys
Ile Lys Glu Gln
Ile Lys Gln Glu
Ile Gln Glu Lys
Lys Glu Ile Gln
Lys Glu Leu Gln
Lys Glu Gln Ile
Lys Glu Gln Leu
Lys Ile Glu Gln
Lys Ile Gln Glu
Lys Leu Glu Gln
Lys Leu Gln Glu
Lys Gln Glu Ile
Lys Gln Glu Leu
Lys Gln Leu Glu
Leu Glu Lys Gln
Leu Glu Gln Lys
Leu Lys Glu Gln
Leu Lys Gln Glu
Leu Gln Glu Lys
Leu Gln Lys Glu
Gln Glu Ile Lys
Gln Glu Lys Ile
Gln Glu Lys Leu
Gln Glu Leu Lys
Gln Ile Glu Lys
Gln Ile Lys Glu
Gln Lys Glu Ile
Gln Lys Glu Leu
Gln Lys Ile Glu
Gln Lys Leu Glu
Gln Leu Glu Lys
Gln Leu Lys Glu
Arg Gly Val Trp
Arg Gly Trp Val
Arg Val Gly Trp
Arg Val Trp Gly
Arg Trp Gly Val
Arg Trp Val Gly
Val Gly Arg Trp
Val Gly Trp Arg
Val Arg Gly Trp
Val Arg Trp Gly
Val Trp Gly Arg
Val Trp Arg Gly
Trp Gly Arg Val
Trp Gly Val Arg
Trp Arg Gly Val
Trp Arg Val Gly
Trp Val Gly Arg
Trp Val Arg Gly
9-[(E)-3-methyl-4-[(2S,3R,4S,5R)-3,4,5-trihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]but-2-enoyl]oxynonanoic acid
2-[2-[(3-amino-3-carboxypropyl)amino]-2-oxoethyl]-4-[3-[[(E)-dec-2-enoyl]-hydroxyamino]propylamino]-2-hydroxy-4-oxobutanoic acid
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(2-morpholin-4-ylacetyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(2-morpholin-4-ylacetyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(2-morpholin-4-ylacetyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
2,3-dihydroxypropyl [2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propyl] hydrogen phosphate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
3-O-(alpha-L-olivosyl)oleandolide
A macrolide that is oleandolide having a 2,6-dideoxy-alpha-L-arabino-hexopyranosyl (alpha-L-olivosyl) residue attached at position 3.
(1r,9s,10s,12s,14e,16s,19r,20r,21s,22r)-3,9-dihydroxy-10,12,14,16,20,21,22-heptamethyl-8-(methylsulfanyl)-23,24-dioxatetracyclo[17.3.1.1⁶,⁹.0²,⁷]tetracosa-2,5,7,14-tetraen-4-one
(1s,3r,5s,7s,8r)-5-benzoyl-8-[(2r)-3,3-dimethyloxiran-2-yl]-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)adamantane-2,4,9-trione
2-(hydroxymethyl)-6-{[1-(hydroxymethyl)-1,4a-dimethyl-7-(1,2,3-trihydroxypropan-2-yl)-2,3,4,4b,5,6,7,8,10,10a-decahydrophenanthren-2-yl]oxy}oxane-3,4,5-triol
3,9-dihydroxy-10,12,14,16,20,21,22-heptamethyl-8-(methylsulfanyl)-23,24-dioxatetracyclo[17.3.1.1⁶,⁹.0²,⁷]tetracosa-2,5,7,14-tetraen-4-one
(1r,3br,4r,5ar,9ar,9br,11as)-3b,6,6,9a,11a-pentamethyl-7-oxo-1-(5-oxo-2h-furan-3-yl)-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl benzoate
({3,13,19-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18(22),19-heptaen-9-yl}oxy)methanimidic acid
2,6-diacetyl-3,4-diisobutyryl-1-o-octylgluco-pyranoside
{"Ingredient_id": "HBIN004873","Ingredient_name": "2,6-diacetyl-3,4-diisobutyryl-1-o-octylgluco-pyranoside","Alias": "NA","Ingredient_formula": "C26H44O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5331","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}